Hi Zenox, noting your scepticism about whether these results imply impact on fibrosis, do you happen to know what the standard treatment is for acute inflammatory response - and how iPPS compares? I suppose what i'm ultimately trying to divine is whether this would be material on it's own and could displace current treatments?
- Forums
- ASX - By Stock
- PAR
- Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
5.00%
!
42.0¢

Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-37
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
42.0¢ |
Change
0.020(5.00%) |
Mkt cap ! $166.9M |
Open | High | Low | Value | Volume |
40.0¢ | 42.5¢ | 39.5¢ | $160.0K | 389.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 39140 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 11642 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 15798 | 0.415 |
9 | 80858 | 0.410 |
5 | 47652 | 0.405 |
7 | 75638 | 0.400 |
3 | 210000 | 0.395 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 11642 | 4 |
0.425 | 8371 | 4 |
0.430 | 10372 | 5 |
0.435 | 1540 | 1 |
0.440 | 57622 | 6 |
Last trade - 12.39pm 22/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |